Overview

Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
0
Participant gender:
All
Summary
Intranasal dexmedetomidine has shown to be an effective sedative when used prior to anaesthetic induction as premedication. 1mcg/kg intranasal dexmedetomidine was used in previous study and it produced satisfactory sedation in more than 50% of the children at the time of anaesthetic induction with no adverse effect. In this study we aim to compare 1mcg/kg with 2mcg/kg intranasal dexmedetomidine in children. We expect more children would attain satisfactory sedation prior to anaesthetic induction when higher dose is used.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
The University of Hong Kong
Treatments:
Dexmedetomidine
Criteria
Inclusion Criteria:

- Age 1-12 years old

- American Society of Anesthesiologists (ASA) 1-2

- Elective surgery

- Children with autism or pervasive personality disorder

Exclusion Criteria:

- American Society of Anaesthesiologists (ASA) 3-5

- Allergy or hypersensitive reaction to dexmedetomidine

- Known cardiac arrhythmia or congenital heart disease

- Mentally disabled